Latest Breaking News On - Lendava lendva - Page 1 : comparemela.com

Swiss pharma s big bet on Slovenia - SWI swissinfo ch

As Swiss companies Novartis and Sandoz shift to complex, expensive medicine, they are increasingly dependent on the tiny Balkan nation of Slovenia.

Slovenia generalUnited statesLendava lendvaLosec prilosecMiha zavrtanikAymeric royereGregor makucKai reusserPolonca kuharSeries swissSecond world warState secretaryNovartis sloveniaHealth organisations

Swiss Pharma s Big Bet On Slovenia

Swiss Pharma s Big Bet On Slovenia
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Slovenia generalLendava lendvaPolonca kuharKai reusserLosec prilosecGregor makucContent behindSecond world warExternal contentState secretary

Slovenia: Ascent Resource s Slovenian JV partner initiates insolvency proceedings

Slovenia: Ascent Resource s Slovenian JV partner initiates insolvency proceedings
energy-pedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from energy-pedia.com Daily Mail and Mail on Sunday newspapers.

United statesLendava lendvaRepublic of sloveniaAscent slovenia limitedGeoenergo is ascent slovenia limitedAscent resourcesHispanic americanArbitration tribunalNafta lendava

BioBlast w/e 15 Dec 23

Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…

South koreaLendava lendvaSamsung biologicsBiomed nona biosciencesNona biosciencesGenentech avastinSeagen astella padcevCelltrion vegzelmaGenentech actemraAbbvie humiraKorea ministry of foodIntas pharmaceuticalsKorean ministry of foodJapan national health insuranceApproval alertKorean ministry

Slovenia s Lek breaks ground for 400 mln euro biosimilars plant | Companies

Slovenian pharmaceutical company Lek started the construction of a 400 million euro ($432 million) biosimilars production plant in Lendava, the government said.

Lendava lendvaSlovenian pharmaceutical company lek started the construction ofa 400 million euro 432 biosimilars production plant in lendavaHe government said